# Flush, Lyse, Operate

> **NCT07592520** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Complicated Parapneumonic Effusion
- Empyema, Pleural

## Interventions

- **DRUG:** Intrapleural Saline with possible escalation to intraplerual alteplase and dornase.

## Key facts

- **NCT ID:** NCT07592520
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07592520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07592520, "Flush, Lyse, Operate". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT07592520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*